# Docebo Inc.: overview

DCBO · Nasdaq · CIK 1829959 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dcbo.md) · [Financials](/companies/dcbo/financials.md) · [Filings](/companies/dcbo/filings.md) · [Insiders](/companies/dcbo/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

Not reported.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [104](/filings/0001628280-23-007142.md) | [143](/filings/0001628280-24-006515.md) | [181](/filings/0001628280-25-008863.md) | [217](/filings/0001628280-26-012566.md) | [243](/filings/0001628280-26-012566.md) |
| Gross margin | % | [80.1%](/filings/0001628280-23-007142.md) | [80.3%](/filings/0001628280-24-006515.md) | [80.9%](/filings/0001628280-25-008863.md) | [81.0%](/filings/0001628280-26-012566.md) | [80.3%](/filings/0001628280-26-012566.md) |
| Operating margin | % | [(12.9%)](/filings/0001628280-23-007142.md) | [2.9%](/filings/0001628280-24-006515.md) | [(2.1%)](/filings/0001628280-25-008863.md) | [9.8%](/filings/0001628280-26-012566.md) | [9.6%](/filings/0001628280-26-012566.md) |
| Net margin | % | [(13.0%)](/filings/0001628280-23-007142.md) | [4.9%](/filings/0001628280-24-006515.md) | [1.6%](/filings/0001628280-25-008863.md) | [12.3%](/filings/0001628280-26-012566.md) | [15.5%](/filings/0001628280-26-012566.md) |
| Diluted EPS | $ per share | [(0.41)](/filings/0001628280-23-007142.md) | [0.21](/filings/0001628280-24-006515.md) | [0.08](/filings/0001628280-25-008863.md) | [0.86](/filings/0001628280-26-012566.md) | [1.28](/filings/0001628280-26-012566.md) |
| Free cash flow | $m | [(4.4)](/filings/0001628280-23-007142.md) | [1.2](/filings/0001628280-24-006515.md) | [15.3](/filings/0001628280-25-008863.md) | [28.0](/filings/0001628280-26-012566.md) | [27.2](/filings/0001628280-26-012566.md) |

- Revenue. XBRL Revenue: ifrs-full:RevenueFromContractsWithCustomers.
- Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:RevenueFromContractsWithCustomers.
- Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:RevenueFromContractsWithCustomers.
- Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLoss; Revenue: ifrs-full:RevenueFromContractsWithCustomers.
- Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dcbo/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Topline Capital Management, LLC](/funds/1792549.md) | 2026-06-30 | $11.9m | 664,727 |  | Reduced −214,177 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $11.1m | 622,304 |  | Added +6,717 |
| [Quadrature Capital Ltd](/funds/1651424.md) | 2026-06-30 | $5.3m | 296,211 |  | Added +191,911 |
| [Sparta 24 Ltd.](/funds/1967706.md) | 2026-06-30 | $3.6m | 199,765 |  | New +199,765 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $3.5m | 196,195 |  | Reduced −77,737 |
| [ESSEX INVESTMENT MANAGEMENT CO LLC](/funds/201772.md) | 2026-06-30 | $3.0m | 165,095 |  | Reduced −7,272 |
| [LOUISBOURG INVESTMENTS INC.](/funds/2053050.md) | 2026-06-30 | $2.9m | 160,037 |  | Added +65,465 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $2.5m | 142,329 |  | Added +104,963 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.9m | 107,831 |  | Reduced −200 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $1.4m | 77,206 |  | Reduced −2,237 |

## Recent filings

[All 135 filings](/companies/dcbo/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-11 | 08:21 ET | [6-K](/filings/0001193125-26-388661.md) | Report of a foreign private issuer, period 2026-09-11 | 0001193125-26-388661 |
| 2026-09-09 | 16:01 ET | [6-K](/filings/0001193125-26-386426.md) | Report of a foreign private issuer, period 2026-09-09 | 0001193125-26-386426 |
| 2026-08-21 | 16:45 ET | [6-K](/filings/0001193125-26-361237.md) | Report of a foreign private issuer, period 2026-08-21 | 0001193125-26-361237 |
| 2026-08-07 | 06:10 ET | [6-K](/filings/0001628280-26-054559.md) | Report of a foreign private issuer, period 2026-06-30 | 0001628280-26-054559 |
| 2026-07-21 | 17:11 ET | [6-K](/filings/0001193125-26-310543.md) | Report of a foreign private issuer, period 2026-07-21 | 0001193125-26-310543 |
| 2026-07-20 | 06:47 ET | [SCHEDULE 13D/A](/filings/0001643560-26-000013.md) | Ownership report, active investor, amended | 0001643560-26-000013 |
| 2026-07-17 | 06:54 ET | [6-K](/filings/0001193125-26-306725.md) | Report of a foreign private issuer, period 2026-07-17 | 0001193125-26-306725 |
| 2026-06-10 | 16:10 ET | [6-K](/filings/0001628280-26-042192.md) | Report of a foreign private issuer, period 2026-06-10 | 0001628280-26-042192 |
| 2026-05-08 | 07:40 ET | [6-K](/filings/0001628280-26-032550.md) | Report of a foreign private issuer, period 2026-03-31 | 0001628280-26-032550 |
| 2026-05-08 | 21:00 ET | [6-K](/filings/0001628280-26-032512.md) | Report of a foreign private issuer, period 2026-05-07 | 0001628280-26-032512 |

## Latest annual report

[Form 40-F for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-012566.md), filed Feb 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1829959
- Tickers: DCBO
- Exchange: Nasdaq
- SIC code: 7372 Services-Prepackaged Software
- State of incorporation: A6
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.
